NCT00417872View on ClinicalTrials.gov

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

September 30, 2005

Conditions
Clostridium Difficile
Interventions
DRUG

Nitazoxanide

DRUG

Metronidazole

Trial Locations (7)

18103

Lehigh Valley Hospital, Allentown

19611

The Reading Hospital and Medical Center, West Reading

30060

WellStar Infectious Diseases, Marietta

33713

Bayfront Medical Center and Edward White Hospital, St. Petersburg

43214

Remington-Davis, Inc., and Riverside Infection Consultants, Inc., Columbus

77030

Houston Veterans Affairs Hospital, Houston

St. Luke's Episcopal Hospital, Houston

All Listed Sponsors
lead

Romark Laboratories L.C.

INDUSTRY

NCT00417872 - Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis | Biotech Hunter | Biotech Hunter